ASLAN Pharmaceuticals, a biotech company focused on the development of immunotherapies and targeted agents for Asia prevalent tumour types, announced its CEO, Dr Carl Firth, has been appointed to serve on the Health and Biomedical Sciences International Advisory Council (IAC) of Singapore.
The IAC is a high-level Council that steers the development of Singapore’s biomedical sector.
Advising the Agency for Science, Technology and Research (A*STAR) and the Ministry of Health, the Council comprises of distinguished medical professionals and eminent scientists from the global biomedical sciences community who share their expertise and insight on industry trends.
Firth said: “ASLAN’s success has been made possible because of the country’s strong biotech ecosystem. I am honoured to join the esteemed Council to contribute to the advancement of Singapore as a global biotech hub.”
The Council is chaired by eminent biochemist Sir Richard Sykes, Chairman of the Imperial College Healthcare NHS Trust. Other members of the Council include Sir Leszek Borysiewicz, Vice Chancellor of the University of Cambridge; Dame Sally Davies, Chief Medical Officer for England; and Professor Victor J Dzau, President of the National Academy of Medicine.
